Marius Seeks FDA Approval of Testosterone Therapy
Raleigh-based Marius Pharmaceuticals, led by several former GlaxoSmithKline scientists and executives, is making progress on its first potential drug.Marius has submitted a New Drug Application (NDA) to the U.S. Food and Read More >>
Shah Capital Invests US$11 Million in ReneSola
SHANGHAI, Oct. 2, 2019 /PRNewswire/ — ReneSola Ltd (“ReneSola” or the “Company”) (www.renesolapower.com) (NYSE: SOL), a leading fully integrated solar project developer, today announced that the Company entered into a definitive share purchase Read More >>
Marius Pharmaceuticals Completes Efficacy Portion of its Re-Tune Phase 3 Study Evaluating Their Innovative Oral Testosterone Undecenoate Formulation in Hypogonadal Men
September 26 2018, Raleigh, NC – Marius Pharmaceuticals, a specialty pharmaceutical company, today announced positive preliminary data for their Phase 3 clinical trial evaluating SOV-2012-F1 in men suffering from hypogonadism. Read More >>
Shah Capital Proposals to be Discussed at the Upcoming June 2018 CYI AGM
China Yuchai International (CYI) 16 Raffles Quay #26-00, Hong Leong Building Singapore 048581 Distinguished Directors of CYI: Shah Capital being the third largest shareholder with 8% of the outstanding shares Read More >>
Vitamin Shoppe to Appoint New Independent Directors to Board
SECAUCUS, N.J., April 23, 2018 SECAUCUS, N.J., April 23, 2018 /PRNewswire/ — Vitamin Shoppe, Inc. (NYSE: VSI), an omni-channel, specialty retailer and contract manufacturer of nutritional products, today announced that Read More >>
Shah Capital Releases Letter to Avon Board
FOR IMMEDIATE RELEASE January 29, 2018 SHAREHOLDER GROUP CALLS ON AVON PRODUCTS BOARD TO EXPLORE THE SALE OF THE COMPANY New York, January 29, 2018 – A group of shareholders Read More >>
Activists Get Avon Board Seat
Avon Products Inc. plans to cede a board seat to an activist investor, the company said Monday, as part of a deal that will help the struggling beauty company avoid Read More >>
ValueWalk’s Value Fund Interview Series
1. To start off, can you tell us a bit about Shah Capital and the team working at the fund? Shah Capital is a global investment firm focusing on deep Read More >>
Genworth Financial (GNW), Avon Products (AVP) Just Some of the Stocks That Powered Shah Capital to Splendid Quarter
Himanshu H. Shah‘s Shah Capital is one of more than 749 hedge funds in our database that filed a 13F for the June 30 reporting period. Of those funds, Shah Capital’s long positions Read More >>